Treatment of renal osteodystrophy

被引：1
|
作者：
Gal-Moscovici A. [1 ,2 ]
Sprague S.M. [2 ,4 ]
Lerma E.V. [3 ]
机构：
[1] Hadassah Hospital Medical Center, Hebrew University, Ein Keren, Jeruslaem
[2] Division of Nephrology and Hypertension, Evanston Northwestern Healthcare, Northwestern University Feinberg School of Medicine, Evanston, IL
[3] Section of Nephrology, University of Illinois at Chicago, College of Medicine/Associates in Nephrology, Chicago, IL
[4] Evanston, IL 60201
来源：
Clinical Reviews in Bone and Mineral Metabolism | 2007年 / 5卷 / 1期
关键词：
Cinacalcet; Parathyroidectomy; Phosphate binders; Renal osteodystrophy; Vitamin D receptor agonist;
D O I：
10.1007/BF02736669
中图分类号：
学科分类号：
摘要：
Chronic kidney disease (CKD) is accompanied by disturbances in calcium, phosphate, vitamin D, and parathyroid hormone (PTH) homeostasis known to play an important role in the pathophysiology of renal osteodystrophy. Increased cardiovascular morbidity and mortality rate among CKD patients, correlates with these disturbances in bone and mineral metabolism and underscores the nephrologist's concern about the effectiveness of the present therapeutic approach. Treatment directed to normalize the calcium/phosphate, vitamin D and PTH abnormalities may adversely affect endothelial, vascular and bone cells activity. This article discusses the therapeutic approaches focuses for renal osteodystrophy. © Copyright 2007 by Humana Press Inc. All rights of any nature whatsoever reserved.
引用
收藏
页码：27 / 38
页数：11
相关论文
共 50 条
  • [21] TREATMENT OF RENAL-GLOMERULAR OSTEODYSTROPHY
    DENT, CE
    HARPER, CM
    PHILPOT, GR
    QUARTERLY JOURNAL OF MEDICINE, 1961, 30 (117): : 1 - &
  • [22] TREATMENT OF FRACTURING RENAL OSTEODYSTROPHY BY DESFERRIOXAMINE
    ACKRILL, P
    DAY, JP
    GARSTANG, FM
    HODGE, KC
    METCALFE, P
    HILL, K
    RALSTON, AJ
    BALL, J
    DENTON, J
    KIDNEY INTERNATIONAL, 1983, 23 (03) : 552 - 552
  • [23] RECENT ADVANCES IN THE TREATMENT OF RENAL OSTEODYSTROPHY
    FOURNIER, A
    MORINIERE, P
    BOUDAILLIEZ, B
    COHENSOLAL, ME
    MAKDASSI, R
    WESTEEL, PF
    SEBERT, JL
    EASTWOOD, JB
    INTERNATIONAL YEARBOOK OF NEPHROLOGY, 1990, : 185 - 214
  • [24] TREATMENT OF EXPERIMENTAL RENAL OSTEODYSTROPHY WITH RISEDRONATE
    Shiizaki, Kazuhiro
    Ito, Chiharu
    Onishi, Akira
    Nakazawa, Eiko
    Ogura, Manabu
    Kusano, Eiji
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 151 - 151
  • [25] Current treatment of renal osteodystrophy in children
    Macher, MA
    Baudouin, V
    Akil, R
    Loirat, C
    ARCHIVES DE PEDIATRIE, 1997, 4 : S91 - S94
  • [26] TREATMENT OF CHILDHOOD RENAL OSTEODYSTROPHY WITH CALCITRIOL OR ERGOCALCIFEROL
    HODSON, EM
    EVANS, RA
    DUNSTAN, CR
    HILLS, E
    WONG, SYP
    ROSENBERG, AR
    ROY, LP
    CLINICAL NEPHROLOGY, 1985, 24 (04) : 192 - 200
  • [27] BONE HISTOMORPHOMETRY IN THE DIAGNOSIS AND TREATMENT OF RENAL OSTEODYSTROPHY
    TEITELBAUM, S
    KIDNEY INTERNATIONAL, 1984, 26 (06) : 896 - 897
  • [28] Prevention and treatment of renal osteodystrophy:: present and future
    Fernandez, E.
    Craver, L.
    NEFROLOGIA, 2006, 26 : 19 - 27
  • [29] Efficacy of calcitriol in the treatment of patients with renal osteodystrophy
    Jiang, Haitao
    Tang, Xiaoming
    Zhang, Cheng
    Dai, Jian
    Lu, Haiyuan
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (02) : 355 - 361
  • [30] THE POSSIBLE USE OF BISPHOSPHONATES IN THE TREATMENT OF RENAL OSTEODYSTROPHY
    MALLUCHE, HH
    CLINICAL NEPHROLOGY, 1992, 38 : S87 - S91
12345